Clinical Trials Logo

Clinical Trial Summary

This study will evaluate the ability of MyoVoice to replace natural speech. Referred to generally as an Augmentative and Alternative Communication (AAC) device, MyoVoice uses electrical signals recorded non-invasively from speech muscles (electromyographic, or EMG, signals) to restore communication for those with vocal impairments that resulted from surgical treatment of laryngeal and oropharyngeal cancers.


Clinical Trial Description

Over 7.5 million people worldwide are unable to vocalize effectively. Among these individuals are cancer survivors who underwent oropharyngeal/laryngeal surgery and must rely on AAC systems such as text-to-speech applications or artificial voice prostheses as substitutes for their natural voice. Yet most of these devices struggle to convey the expressive attributes of speech (prosody), leading to poor comprehension and a lack of emotional content. The clinical trial will investigate the feasibility of MyoVoice-a novel AAC device that uses surface EMG signals to extract patterns for understanding vocabulary and expressive attributes from articulatory musculature during silently mouthed speech-to effectively restore conversational capabilities for individuals living with vocal impairments due to surgical treatment of laryngeal and oropharyngeal cancers. Patients who underwent a total laryngectomy will be asked to communicate with a conversational partner by silently mouthing words using MyoVoice. The device performance will be evaluated in terms of its ability to accurately and quickly translate articulatory muscle activity into audible speech. MyoVoice will also be compared to that of conventional electrolaryngeal speech aids (i.e., artificial larynx) to evaluate device ease-of-use, functional efficacy, and social reception. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04762043
Study type Interventional
Source Altec Inc.
Contact Jennifer M Vojtech, PhD
Phone 5085458208
Email jvojtech@altecresearch.com
Status Recruiting
Phase N/A
Start date February 12, 2021
Completion date March 2023

See also
  Status Clinical Trial Phase
Recruiting NCT02909088 - Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering). Phase 2/Phase 3
Recruiting NCT05695131 - Clinical Feasibility & Validation of the Virtual Reality GlenxRose Speech-Language Therapies N/A
Recruiting NCT04117360 - Orthognathic Speech Pathology: Phonetic Contrasts of Patients With Dental Discrepancies Pre- and Post-Treatment Analyses
Completed NCT02490826 - Table to Tablet (T2T): A Novel Intervention Framework for Children With Speech Sound Disorders N/A
Completed NCT02288598 - Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering N/A
Not yet recruiting NCT04528147 - Yi Jin Jing Tiger Roaring Speech Rehabilitation With Real-Time Feedback Technique for PD N/A
Completed NCT02554513 - Apraxia of Speech: Comparison of EPG Treatment (Tx) and Sound Production Treatment (SPT) N/A
Recruiting NCT05876247 - Articulatory Adaptation Following Oral Cancer Treatment
Recruiting NCT05489965 - Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis)
Completed NCT02752425 - Visual Feedback of Tongue by Ultrasound Echography for Speech Trouble Rehabilitation N/A
Recruiting NCT06443073 - The Mere-measurement Effect of Patient-reported Outcomes N/A
Recruiting NCT05741853 - Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia N/A
Completed NCT04026581 - Real World Testing of a Brain-Computer Interface
Active, not recruiting NCT04937452 - Dopaminergic Therapy for Frontotemporal Dementia Patients Phase 2
Completed NCT02416856 - Brain Connectivity Supporting Language Recovery in Aphasia
Completed NCT01180309 - Lingual Frenum and Articulation of Phonemes N/A
Completed NCT03663972 - Age-related Correlates of Treatment for Late-acquired Sounds N/A
Not yet recruiting NCT04323085 - Speech-in-Noise Treatments for Hypophonia in Parkinson's Disease Phase 2
Completed NCT00125242 - Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis N/A
Completed NCT04966689 - The Effect of Combined Speech and Music-therapy on the Speech Characteristics of People With Parkinson's Disease (PD) N/A